These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33908358)

  • 1. Placebo-controlled trials of Covid-19 vaccines - Are they still ethical?
    Ortiz-Millán G
    Indian J Med Ethics; 2021; VI(2):1-8. PubMed ID: 33908358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing vaccines in the time of Covid: The changing landscape.
    Cash RA
    Indian J Med Ethics; 2021; VI(2):1-4. PubMed ID: 33908357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problematic Covid-19 vaccine trials in times of vaccine nationalism.
    Ravinetto R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo in new Covid-19 vaccine trials: data quality prioritised over participants' rights.
    Srinivasan S
    Indian J Med Ethics; 2021; VI(2):1-6. PubMed ID: 33908351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The continued use of placebo arms in COVID-19 vaccine trials does not adequately protect the well-being of participants.
    Haire B
    Indian J Med Ethics; 2021; VI(2):1-10. PubMed ID: 33908354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19, the WHO, and the apparent collapse of traditional medical research ethics.
    Tangwa GB
    Indian J Med Ethics; 2021; VI(2):1-12. PubMed ID: 33908349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "No" to placebo-controlled trials of Covid-19 vaccines.
    Ahmad A; Dhrolia MF
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical limits to placebo use and access to Covid-19 vaccines as a human right.
    Greco DB
    Indian J Med Ethics; 2021; VI(2):1-14. PubMed ID: 33908350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo control in Covid-19 trials: A missed opportunity for international guidance.
    Wiesing U; Ehni HJ
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trials for second generation Covid-19 vaccines: Revisiting the debate over placebo use in developing country clinical trials.
    Lurie P
    Indian J Med Ethics; 2021; VI(2):1-10. PubMed ID: 33908352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covid-19 vaccine trials and ethics: Protection delayed is protection denied.
    John TJ; Dharmapalan D
    Indian J Med Ethics; 2021; VI(1):1-5. PubMed ID: 34080997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.
    Steel R; Buchak L; Eyal N
    J Med Ethics; 2020 Dec; 46(12):808-812. PubMed ID: 32661074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine trials: The use of active controls and non-inferiority studies.
    Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM
    Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine trials: The potential for "hybrid" analyses.
    Fleming TR; Nason M; Krause PR; Longini IM; Henao-Restrepo AM
    Clin Trials; 2021 Aug; 18(4):391-397. PubMed ID: 34041932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenge Trials: What Are the Ethical Problems?
    Hausman DM
    J Med Philos; 2021 Jan; 46(1):137-145. PubMed ID: 33236048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines for low- and middle-income countries.
    Choi EM
    Trans R Soc Trop Med Hyg; 2021 May; 115(5):447-456. PubMed ID: 33733663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations.
    He Q; Mao Q; Zhang J; Bian L; Gao F; Wang J; Xu M; Liang Z
    Front Immunol; 2021; 12():669339. PubMed ID: 33912196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccines: ethical framework concerning human challenge studies.
    Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
    Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.